U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. grew its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 20.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 299,791 shares of the company's stock after buying an additional 50,163 shares during the quarter. Envestnet Asset Management Inc. owned 1.99% of U.S. Physical Therapy worth $26,594,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. CBIZ Investment Advisory Services LLC grew its stake in U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after purchasing an additional 122 shares in the last quarter. Venturi Wealth Management LLC increased its stake in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after buying an additional 704 shares during the period. Pacer Advisors Inc. bought a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at about $113,000. Mutual of America Capital Management LLC bought a new position in U.S. Physical Therapy during the 4th quarter worth about $203,000. Finally, KLP Kapitalforvaltning AS purchased a new position in U.S. Physical Therapy during the 4th quarter valued at about $257,000.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. This represents a 19.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 1.70% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently commented on USPH. StockNews.com downgraded shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Thursday. Barrington Research reduced their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Finally, JPMorgan Chase & Co. decreased their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Stock Performance

Shares of NYSE:USPH traded down $1.18 on Friday, hitting $67.28. 90,376 shares of the company were exchanged, compared to its average volume of 106,173. The firm has a market capitalization of $1.02 billion, a P/E ratio of 71.57, a price-to-earnings-growth ratio of 3.54 and a beta of 1.38. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock's 50 day moving average price is $76.83 and its 200 day moving average price is $84.88. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $108.14.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. Sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 14th were issued a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.68%. The ex-dividend date was Friday, March 14th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's payout ratio is 97.83%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.